Rifadin — Class II drug recall D-841-2013
Terminated recall by Sanofi US, reported 2013-08-14, distributed nationwide. Subpotent drug: low fill volume in some of the capsules
| Recall number | D-841-2013 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Sanofi US, Bridgewater, NJ, United States |
| Recall initiated | 2013-03-07 |
| Classified | 2013-08-05 |
| Reported by FDA | 2013-08-14 |
| Terminated | 2014-03-17 |
| Distributed | Nationwide (US) |
| Quantity | 2,462 bottles |
| Reason classes | potency |
| NDC | 00068-0510-30 |
| Lot numbers | 3/15, 3097657 |
Product
Rifadin, Rifampin capsules, 150 mg, packaged in 30-count bottle, Rx only, Mfd. for Sanofi-Aventis, U.S., LLC, Bridgewater, NJ 08807, NDC 0068-0510-30
Reason for recall
Subpotent drug: low fill volume in some of the capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-841-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.